At-home tests for GLP-1s may include: Utilizing dried blood spot cards, remote tests for GLP-1s allow patients to collect capillary blood through a finger prick and blot a specialized filter paper
Additionally, discrepancies in findings from other LC supplementation meta-analyses may be attributed to differences in population characteristics, types of interventions, sample sizes, study quality, and measurement methods, complicating the assessment of LCs effects across different patient groups
Who Should Consider GLP-1 Therapy and When Weight Rebound Risk Matters Most GLP-1 therapy is most appropriate for patients with BMI 27 kg/m with weight-related comorbidities, BMI 30 kg/m, or those with type 2 diabetes
Indirect mechanisms relate to weight loss, improved glycaemic control, and reduced visceral adiposityall of which independently contribute to lower inflammatory burden
DOI: Publisher Name: Springer, Berlin, Heidelberg Print ISBN: 978-3-540-42843-5 Online ISBN: 978-3-540-29832-8 eBook Packages: Springer Book Archive